Home | FibroGen | BioPharma for Anemia, Fibrosis, Cancer

We create first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.

Pipeline

We are developing products with the potential to change lives.

Clinical Trials

We are dedicated to responsibly developing groundbreaking therapies for serious and life-threatening diseases.

FibroGen China

We have taken an unprecedented approach to introducing world-class innovations in China.

Jun 10, 2019: FibroGen to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
Jun 5, 2019: FibroGen Appoints Suzanne Blaug to Board of Directors
May 9, 2019: FibroGen Reports First Quarter 2019 Financial Results
May 9, 2019: FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program
May 6, 2019: FibroGen to Report First Quarter 2019 Financial Results

View All

FG Culture

“Being surrounded by so many intelligent, kind, and professional people makes FibroGen a wonderful place to work.”

Associate Scientist II, Cell Biology

Contact Our Company

We are growing a dedicated team committed to innovation and helping patients worldwide.